Gennex Laboratories Limited (BOM:531739)
India · Delayed Price · Currency is INR 10.16
-0.05 (-0.49%)
At close: Apr 16, 2026
Gennex Laboratories Market Cap
Gennex Laboratories has a market cap or net worth of 2.47 billion as of April 16, 2026. Its market cap has decreased by -22.81% in one year.
Market Cap
2.47B
Enterprise Value
2.96B
Revenue
1.52B
Ranking
n/a
PE Ratio
13.60
Stock Price
10.16
Market Cap Chart
Since January 2, 2002, Gennex Laboratories's market cap has increased from 61.80M to 2.47B, an increase of 3,893.86%. That is a compound annual growth rate of 16.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 2.47B | -24.11% |
| Dec 31, 2025 | 3.25B | -12.43% |
| Dec 31, 2024 | 3.71B | 24.52% |
| Dec 29, 2023 | 2.98B | 160.77% |
| Dec 30, 2022 | 1.14B | -18.17% |
| Dec 31, 2021 | 1.40B | 135.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kerala Ayurveda | 3.24B |
| Medico Remedies | 3.21B |
| Medicamen Biotech | 3.14B |
| Sat Kartar Life | 3.10B |
| Trident Lifeline | 3.02B |
| Everest Organics | 2.40B |
| Sanjivani Paranteral | 2.21B |
| Ambalal Sarabhai Enterprises | 2.21B |